NCT00346242View on ClinicalTrials.gov

Evaluation of Efficacy of Zoledronic Acid in Patients With Haemoglobin Syndromes (Thalassemia and Sicle Cell Anaemia) and Risk of Skeletal Events

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

March 31, 2006

Conditions
Thalassemia
Interventions
DRUG

Zoledronic Acid

Trial Locations (1)

Unknown

Novartis Investigative Site, Athens

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY